Multicentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol

Elena Kum, Wafa Hassan, Sue Beaudin, Geoff Strong, Kim Smith, Ana Oliveira, Mustafa Al-Saiedy, Renata Mancopes, Ana Sofia Grave, Melanie Bernier, Anurag Bhalla, Danica L Brister, Andréanne Côté, Simon Couillard, Stephen K Field, Faye Johnston, Robert Newman, Nada Popovic, Alan G Kaplan, Dina Brooks, Gordon Guyatt, Imran Satia

Open source

DOI: 10.1136/bmjopen-2026-126545
Published: 2026-09
Container: BMJ Open
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2026-126545,
  title = {Multicentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol},
  author = {Elena Kum and Wafa Hassan and Sue Beaudin and Geoff Strong and Kim Smith and Ana Oliveira and Mustafa Al-Saiedy and Renata Mancopes and Ana Sofia Grave and Melanie Bernier and Anurag Bhalla and Danica L Brister and Andréanne Côté and Simon Couillard and Stephen K Field and Faye Johnston and Robert Newman and Nada Popovic and Alan G Kaplan and Dina Brooks and Gordon Guyatt and Imran Satia},
  year = {2026},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2026-126545},
  url = {https://doi.org/10.1136/bmjopen-2026-126545}
}

RIS

TY  - JOUR
TI  - Multicentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol
AU  - Elena Kum
AU  - Wafa Hassan
AU  - Sue Beaudin
AU  - Geoff Strong
AU  - Kim Smith
AU  - Ana Oliveira
AU  - Mustafa Al-Saiedy
AU  - Renata Mancopes
AU  - Ana Sofia Grave
AU  - Melanie Bernier
AU  - Anurag Bhalla
AU  - Danica L Brister
AU  - Andréanne Côté
AU  - Simon Couillard
AU  - Stephen K Field
AU  - Faye Johnston
AU  - Robert Newman
AU  - Nada Popovic
AU  - Alan G Kaplan
AU  - Dina Brooks
AU  - Gordon Guyatt
AU  - Imran Satia
PY  - 2026
JO  - BMJ Open
DO  - 10.1136/bmjopen-2026-126545
UR  - https://doi.org/10.1136/bmjopen-2026-126545
ER  -

APA

Kum, E., Hassan, W., Beaudin, S., Strong, G., Smith, K., Oliveira, A., Al-Saiedy, M., Mancopes, R., Grave, A. S., Bernier, M., Bhalla, A., Brister, D. L., Côté, A., Couillard, S., Field, S. K., Johnston, F., Newman, R., Popovic, N., Kaplan, A. G., Brooks, D., Guyatt, G., & Satia, I. (2026). Multicentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol. BMJ Open. https://doi.org/10.1136/bmjopen-2026-126545

Source records

crossref · retrieved 2026-09-26T09:21:09.114Z